SYRS

Syros Pharmaceuticals, Inc. Common Stock
SYRS

Overview Fund Activity
Delisted

SYRS was delisted on the 19th of March, 2025.

Back to rankings

93 hedge funds and large institutions have $405M invested in Syros Pharmaceuticals, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 21 increasing their positions, 37 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
+14
Holders Change %
+17.72%
% of All Funds
1.88%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
22
Increased
21
Reduced
37
Closed
8
Calls
$11K
Puts
$24K
Net Calls
-$13K
Net Calls Change
-$954K

Top Buyers

1
AIM
ARK Investment Management
Florida
+$23.9M
2
State Street
State Street
Massachusetts
+$7.55M
3
CIA
Capital Impact Advisors
Massachusetts
+$1.49M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.17M
5
HIM
Hillsdale Investment Management
Ontario, Canada
+$683K

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$7.74M
2
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$4.79M
3
NAMA
Nikko Asset Management Americas
New York
-$4.61M
4
AVM
Arch Venture Management
Illinois
-$1.77M
5
SB
Samsara BioCapital
California
-$1.35M
Name Holding Trade Value Shares
Change 		Shares
Change %
AIM
1
ARK Investment Management
Florida
$99.1M +$23.9M +269,938 +32%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$58.6M +$91.5K +1,035 +0.2%
Sumitomo Mitsui Trust Group
3
Sumitomo Mitsui Trust Group
Japan
$37M -$4.79M -54,242 -11%
NAMA
4
Nikko Asset Management Americas
New York
$36.3M -$4.61M -53,124 -11%
BlackRock
5
BlackRock
New York
$29.3M -$115K -1,303 -0.4%
FP
6
Flagship Pioneering
Massachusetts
$26M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$18M +$1.17M +13,205 +7%
State Street
8
State Street
Massachusetts
$15M +$7.55M +85,433 +101%
SB
9
Samsara BioCapital
California
$11.6M -$1.35M -16,395 -10%
JPMorgan Chase & Co
10
JPMorgan Chase & Co
New York
$7.01M -$579K -6,052 -8%
BBA
11
Baker Bros. Advisors
New York
$6.1M – – –
Point72 Asset Management
12
Point72 Asset Management
Connecticut
$5.82M -$7.74M -87,593 -57%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$5.13M +$149K +1,691 +3%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$4.98M -$8.58K -97 -0.2%
AG
15
Artal Group
Luxembourg
$4.12M -$217K -2,450 -5%
Northern Trust
16
Northern Trust
Illinois
$4.08M -$266K -3,014 -6%
PCM
17
Portolan Capital Management
Massachusetts
$3.99M -$423K -4,781 -10%
Charles Schwab
18
Charles Schwab
California
$2.15M -$68.8K -778 -3%
RG
19
Redmile Group
California
$1.88M – – –
AVM
20
Arch Venture Management
Illinois
$1.77M -$1.77M -20,000 -50%
D.E. Shaw & Co
21
D.E. Shaw & Co
New York
$1.69M -$365K -4,125 -18%
Two Sigma Advisers
22
Two Sigma Advisers
New York
$1.61M -$1.77K -20 -0.1%
Nuveen Asset Management
23
Nuveen Asset Management
Illinois
$1.6M -$196K -2,213 -11%
CIA
24
Capital Impact Advisors
Massachusetts
$1.49M +$1.49M +16,860 New
SCM
25
Sio Capital Management
New York
$1.47M -$938K -10,612 -39%
1
2 3 4